[1]
Andra, C.A. et al. 2023. Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients . Narra J. 3, 3 (Dec. 2023), e409. DOI:https://doi.org/10.52225/narra.v3i3.409.